Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol and Lisinopril in Stage 2 Diastolic Hypertension
NCT01218100Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Oct 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of nebivolol and lisinopril in hypertension (HTN), sponsored by Forest Laboratories. Started Oct 2010; status: completed.
02
Drugs
nebivolollisinopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01218100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218100.